Literature DB >> 24037183

CD52 as both a marker and an effector molecule of T cells with regulatory action: Identification of novel regulatory T cells.

Buka Samten.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24037183      PMCID： PMC4002393          DOI： 10.1038/cmi.2013.38

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  12 in total

Review 1.  CD4+ Tregs and immune control.

Authors:  Zoltán Fehérvari; Shimon Sakaguchi
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

2.  From vanilla to 28 flavors: multiple varieties of T regulatory cells.

Authors:  Ethan M Shevach
Journal:  Immunity       Date:  2006-08       Impact factor: 31.745

3.  CD52 is a novel costimulatory molecule for induction of CD4+ regulatory T cells.

Authors:  Tomoko Watanabe; Jun-ichi Masuyama; Yoshiaki Sohma; Hiroko Inazawa; Kaori Horie; Kumiko Kojima; Yasunori Uemura; Yumi Aoki; Shuji Kaga; Seiji Minota; Toshiyuki Tanaka; Yasunori Yamaguchi; Tetsuto Kobayashi; Isao Serizawa
Journal:  Clin Immunol       Date:  2006-06-22       Impact factor: 3.969

4.  Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies.

Authors:  Maher Albitar; Kim-Anh Do; Marcella M Johnson; Francis J Giles; Iman Jilani; Susan O'Brien; Jorge Cortes; Deborah Thomas; Laura Z Rassenti; Thomas J Kipps; Hagop M Kantarjian; Michael Keating
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

5.  Structure of the CAMPATH-1 antigen, a glycosylphosphatidylinositol-anchored glycoprotein which is an exceptionally good target for complement lysis.

Authors:  M Q Xia; G Hale; M R Lifely; M A Ferguson; D Campbell; L Packman; H Waldmann
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

6.  Primary structure of CD52.

Authors:  A Treumann; M R Lifely; P Schneider; M A Ferguson
Journal:  J Biol Chem       Date:  1995-03-17       Impact factor: 5.157

Review 7.  Human regulatory T cells: a unique, stable thymic subset or a reversible peripheral state of differentiation?

Authors:  Vinodh Pillai; Nitin J Karandikar
Journal:  Immunol Lett       Date:  2007-09-29       Impact factor: 3.685

8.  Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.

Authors:  Bole Tian; Jianqiang Hao; Yu Zhang; Lei Tian; Huimin Yi; Timothy D O'Brien; David E R Sutherland; Bernhard J Hering; Zhiguang Guo
Journal:  Transplantation       Date:  2009-01-27       Impact factor: 4.939

9.  In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes.

Authors:  Qizhi Tang; Kammi J Henriksen; Mingying Bi; Erik B Finger; Greg Szot; Jianqin Ye; Emma L Masteller; Hugh McDevitt; Mark Bonyhadi; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2004-06-07       Impact factor: 14.307

10.  CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer.

Authors:  Kristin V Tarbell; Mark Lee; Erik Ranheim; Cheng Chi Chao; Maija Sanna; Seon-Kyeong Kim; Peter Dickie; Luc Teyton; Mark Davis; Hugh McDevitt
Journal:  J Exp Med       Date:  2002-08-19       Impact factor: 14.307
View more
  4 in total

1.  Establishment a CHO Cell Line Expressing Human CD52 Molecule.

Authors:  Kadijeh Tati; Mahsa Yazdanpanah-Samani; Amin Ramezani; Elham Mahmoudi Maymand; Abbas Ghaderi
Journal:  Rep Biochem Mol Biol       Date:  2016-10

2.  Integrated single-cell analysis of multicellular immune dynamics during hyperacute HIV-1 infection.

Authors:  Bruce D Walker; Alex K Shalek; Samuel W Kazer; Toby P Aicher; Daniel M Muema; Shaina L Carroll; Jose Ordovas-Montanes; Vincent N Miao; Ang A Tu; Carly G K Ziegler; Sarah K Nyquist; Emily B Wong; Nasreen Ismail; Mary Dong; Amber Moodley; Bonnie Berger; J Christopher Love; Krista L Dong; Alasdair Leslie; Zaza M Ndhlovu; Thumbi Ndung'u
Journal:  Nat Med       Date:  2020-03-23       Impact factor: 53.440

3.  High expression of CD52 in adipocytes: a potential therapeutic target for obesity with type 2 diabetes.

Authors:  Rui Mao; Fan Yang; Yu Zhang; Hongtao Liu; Pengsen Guo; Yanjun Liu; Tongtong Zhang
Journal:  Aging (Albany NY)       Date:  2021-03-11       Impact factor: 5.682

Review 4.  Targeted Approaches to T-Cell Lymphoma.

Authors:  Sean Harrop; Chathuri Abeyakoon; Carrie Van Der Weyden; H Miles Prince
Journal:  J Pers Med       Date:  2021-05-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.